Search Results - "Esmeralci Ferreira"

Refine Results
  1. 1
  2. 2

    Clinical Outcomes and Cost-Effectiveness Analysis of FFR Compared with Angiography in Multivessel Disease Patient by Quintella, Edgard Freitas, Ferreira, Esmeralci, Azevedo, Vitor Manuel Pereira, Araujo, Denizar V, Sant'Anna, Fernando Mendes, Amorim, Bernardo, Albuquerque, Denilson Campos de

    Published in Arquivos brasileiros de cardiologia (01-01-2019)
    “…In multivessel disease patients with moderate stenosis, fractional flow reserve (FFR) allows the analysis of the lesions and guides treatment, and could…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Custo-efetividade do Stent Farmacológico na Intervenção Coronariana Percutânea no SUS by Pessoa, João Addison, Ferreira, Esmeralci, Araújo, Denizar Viana, Maia, Edirley, Silva, Felipe Souza Maia da, Oliveira, Maurício Salles de, Albuquerque, Denilson Campos de

    Published in Arquivos brasileiros de cardiologia (01-08-2020)
    “…Resumo Fundamento O uso do stent farmacológico (SF) comparado ao stent não farmacológico (SNF) na intervenção coronariana percutânea (ICP) reduziu o percentual…”
    Get full text
    Journal Article
  7. 7

    Desnervação simpática renal no tratamento da hipertensão arterial resistente : perspectivas atuais by Brandão, Andréa Araujo, Campana, Erika Maria Gonçalves, Magalhães, Maria Eliane Campos, Ferreira, Esmeralci

    Published in Arquivos brasileiros de cardiologia (01-10-2013)
    “…Os autores revisam o conceito de hipertensão arterial resistente e o envolvimento do sistema nervoso simpático na hipertensão arterial como base racional para…”
    Get full text
    Journal Article
  8. 8

    Clinical Profile and its Associations with Coronary Angiography Results in a Public University Hospital by Costa, Guilherme, Ferreira, Esmeralci, Albuquerque, Denilson Campos

    “…Abstract Background: Ischemic heart disease is one of the most common causes of death worldwide. There are few data in the literature about the association of…”
    Get full text
    Journal Article
  9. 9

    Abstract P354: Circulating Interleukin 17 A In Patients With Acute And Chronic Coronary Syndrome by Oliveira, Dinaldo C, Mendes Filho, Edivaldo, Barros, Mariana, Oliveira, Carolina, Cabral, Joao Vitor, Ferreira, Esmeralci

    Published in Circulation research (03-09-2021)
    “…IntroductionInterleukin L-17 is produced by Th 17 cells and other cells. There is a debate if IL 17 is atherogenic or atheroprotective. The true role of this…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Cost-effectiveness of Drug-Eluting Stents in Percutaneous Coronary Intervention in Brazil's Unified Public Health System (SUS) by Pessoa, João Addison, Ferreira, Esmeralci, Araújo, Denizar Viana, Maia, Edirley, Silva, Felipe Souza Maia da, Oliveira, Maurício Salles de, Albuquerque, Denilson Campos de

    Published in Arquivos brasileiros de cardiologia (01-07-2020)
    “…Background The use of drug-eluting stents (DESs), compared with bare-metal stents (BMSs), in percutaneous coronary intervention (PCI) has reduced the rate of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Circulating interleukin-17A in patients with acute and chronic coronary syndromes by Oliveira, Dinaldo C, Oliveira, Carolina G C, Mendes, Jr, Edivaldo B, Silveira, Maria M, Cabral, João V, Ferreira, Esmeralci

    Published in American journal of cardiovascular disease (01-01-2021)
    “…Interleukin 17 (IL-17) is produced by Th17 and other cells. It is debatable whether IL-17 is atherogenic or atheroprotective. The role of this interleukin in…”
    Get full text
    Journal Article